Impact Biomedical (IBO) Return on Assets [ROA] (2023 - 2026)
Impact Biomedical (IBO) reported Return on Assets [ROA] of 9.69% for Q3 2026, up 247.09 percentage points from -237.40% a year earlier and up 5.10 percentage points from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Impact Biomedical posted Return on Assets [ROA] of -62.98%, up 13.33 percentage points from FY2024.
- By year, Return on Assets [ROA] came in at -76.31% in FY2024 (-66.63 pp) and -9.67% in FY2023.
- The Q3 2026 figure ranks as the highest quarterly Return on Assets [ROA] in data going back to Q3 2023.
- Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of -12.45 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q3 2026 (a gain of 247.09 percentage points); the low point was Q3 2025 (a drop of 239.82 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 4.59% (Q2 2026), -74.66% (Q1 2026) and -66.66% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 2.00% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 9.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.69% |
| Jun 30, 2026 | 4.59% |
| Mar 31, 2026 | -74.66% |
| Dec 31, 2025 | -66.66% |
| Sep 30, 2025 | -237.40% |
| Jun 30, 2025 | -196.99% |
| Mar 31, 2025 | -124.21% |
| Dec 31, 2024 | -73.97% |
| Sep 30, 2024 | 2.42% |
| Jun 30, 2024 | -9.77% |
| Mar 31, 2024 | -10.24% |
| Dec 31, 2023 | -9.83% |
| Sep 30, 2023 | -14.30% |
API Access
Impact Biomedical Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();